Literature DB >> 12009693

Homogenous assays for Escherichia coli DnaB-stimulated DnaG primase and DnaB helicase and their use in screening for chemical inhibitors.

Yi Zhang1, Fude Yang, Yeh-Chih Kao, Michael G Kurilla, David L Pompliano, Ira B Dicker.   

Abstract

Escherichia coli DnaG primase is a single-stranded DNA-dependent RNA polymerase. Primase catalyzes the synthesis of a short RNA primer to initiate DNA replication at the origin and to initiate Okazaki fragment synthesis for synthesis of the lagging strand. Primase activity is greatly stimulated through its interaction with DnaB helicase. Here we report a 96-well homogeneous scintillation proximity assay (SPA) for the study of DnaB-stimulated E. coli primase activity and the identification of E. coli primase inhibitors. The assay uses an adaptation of the general priming reaction by employing DnaG primase, DnaB helicase, and ribonucleotidetriphosphates (incorporation of [(3)H]CTP) for in vitro primer synthesis on single-stranded oligonucleotide and M13mp18 DNA templates. The primase product is captured by polyvinyl toluene-polyethyleneimine-coated SPA beads and quantified by counting by beta-scintography. In the absence of helicase as a cofactor, primer synthesis is reduced by 85%. The primase assay was used for screening libraries of compounds previously identified as possessing antimicrobial activities. Primase inhibitory compounds were then classified as direct primase inhibitors or mixed primase/helicase inhibitors by further evaluation in a specific assay for DnaB helicase activity. By this approach, specific primase inhibitors could be identified. (c) 2002 Elsevier Science (USA)

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009693     DOI: 10.1006/abio.2002.5627

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Inhibition of DNA replication in Staphylococcus aureus by tegaserod.

Authors:  Christopher J Lacriola; Shaun P Falk; Bernard Weisblum
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

2.  Coumarin-based inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicase: chemical optimization, biological evaluation, and antibacterial activities.

Authors:  Bing Li; Ramdas Pai; Ming Di; Daniel Aiello; Marjorie H Barnes; Michelle M Butler; Tommy F Tashjian; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  J Med Chem       Date:  2012-12-11       Impact factor: 7.446

3.  Discovery, characterization and comparison of inhibitors of Bacillus anthracis and Staphylococcus aureus replicative DNA helicases.

Authors:  Daniel Aiello; Marjorie H Barnes; Esther E Biswas; Subhasis B Biswas; Shen Gu; John D Williams; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2009-05-12       Impact factor: 3.641

4.  Optimization of a novel potent and selective bacterial DNA helicase inhibitor scaffold from a high throughput screening hit.

Authors:  Bing Li; Ramdas Pai; Daniel Aiello; Ming Di; Marjorie H Barnes; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem Lett       Date:  2013-04-30       Impact factor: 2.823

Review 5.  The bacterial helicase-primase interaction: a common structural/functional module.

Authors:  Panos Soultanas
Journal:  Structure       Date:  2005-06       Impact factor: 5.006

Review 6.  Architecture and conservation of the bacterial DNA replication machinery, an underexploited drug target.

Authors:  Andrew Robinson; Rebecca J Causer; Nicholas E Dixon
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

Review 7.  Alternative pre-approved and novel therapies for the treatment of anthrax.

Authors:  Breanne M Head; Ethan Rubinstein; Adrienne F A Meyers
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

8.  A novel non-radioactive primase-pyrophosphatase activity assay and its application to the discovery of inhibitors of Mycobacterium tuberculosis primase DnaG.

Authors:  Tapan Biswas; Esteban Resto-Roldán; Sean K Sawyer; Irina Artsimovitch; Oleg V Tsodikov
Journal:  Nucleic Acids Res       Date:  2012-12-24       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.